New drug combo aims to shrink Hard-to-Treat cancers
Disease control
Recruiting now
This study tests a combination of two experimental drugs, HX009 and IN10018, with or without standard chemotherapy, in people with advanced solid tumors like biliary tract cancer and melanoma. The goal is to find the best dose and see if the combination can shrink tumors. About 1…
Phase: PHASE1, PHASE2 • Sponsor: Hangzhou Hanx Biopharmaceuticals, Ltd. • Aim: Disease control
Last updated Jun 17, 2026 12:07 UTC